Ernest Lim's investing blog

Unique insights into SGX small caps

dividend

Sing Medical – Chart seems to be strengthening (13 Feb 2019)

el15

This week, Sing Medical’s (“SMG”) caught my attention. At the time of writing this write-up, SMG is trading +0.005 to $0.430. Day range 0.425 – 0.430.   Some interesting observations on SMG a) Chart seems to be strengthening Based on Chart 1 below, SMG seems to have breached the near term downtrend line established since Mar 2018. Today is T+7 of the sharp upmove dated 31 Jan 2019 thus, I guess those contra players (who plan to contra and not hold the stock) have already exited. Indicators such as OBV, RSI and MACD are strengthening. ADX last trades 34.5 on […]

SIA Engineering trades at 9-year low price and 10-year low valuations (26 Dec 18)

el15

SIA Engineering (“SIE”) catches my attention this week because 1) Share price has fallen to the lows last seen in May 2009 – 9 +year low with negative news, more or less well known. It last trades at $2.20 on 26 Dec 2018. Based on Maybank’s report out this month, SIE management has flagged out challenges in their industry approximately two years ago –> on lower maintenance frequency required by newer aircraft and fleet growth at low cost carriers (“LCC”) requiring SIE to think of new solutions to reduce aircraft downtime at hangars; 2) At $2.20, RSI last trades at […]

STI has dropped almost 17% since 2 May! Is a bear market coming? (14 Oct 18)

el15

Dear all, U.S. equity markets have logged their worst weekly performance in the past six months. For our local market, STI has dropped 16.7% from an intra-day high of 3,642 on 2 May 2018 to an intra-day low of 3,035 on 11 Oct 2018. It closed at 3,069 on 12 Oct 2018. Is a bear market coming? There are mixed views. Bears are saying that we have not reached the bottom yet. Some perma-bears are even saying this may be the start of the bear market. Bulls are saying that this represents a window of opportunity to accumulate stocks on […]

Sing Medical trades near one year low despite a 70% jump in 1HFY18 net profit! (3 Oct 2018)

el15

This week, Sing Medical (“SMG”) caught my attention. SMG has dropped 39% from $0.725 on 18 Jul 2017 to trade $0.440 on 3 Oct 2018. My personal guess is part of the fall may be attributable to a) Lower, or no earnings growth for some of the healthcare players in FY18F. However, this is likely not the case for SMG, as analysts believe SMG is on track for a minimum 40% growth in FY18F net profit. It is noteworthy that SMG already posted a 70% jump in 1HFY18 net profit; b) Reduction in the general PE valuations ascribed to the […]

Singtel hits multi-year low and all time oversold since 2000! (3 Jul 2018)

el15

Singtel closed -$0.03 to $3.02, the lowest close since Jun 2012. Based on Bloomberg, it is trading at approximately 5.9% estimated div yield. Ave analyst target is around $3.92. Hence total potential upside is around 35.7%. What has happened to Singtel which hit multi-year lows despite analysts’ buy calls? Is this a buying opportunity? Or is it a falling knife?   Singtel – takeaways from some analyst reports The recent weakness in Singtel may be attributed to its challenging industry, especially when the industry faces new entrants in both Singapore and Australia. Although Singtel may lack near term catalysts, based […]

EC World Reit – potential strong growth ahead (29 Jun 18)

el15

Dear all, Reits are clearly not in our investors’ favour as evidenced by the 10.2% fall in FTSE Reit index (FSTAS8670.IN), which closed 786 on 29 Jun 2018, after hitting a multi-year high of 875 in Jan 2018. Most analysts or strategists will recommend reits with distribution per unit (“DPU”) growth, so as to combat the rise in interest rates. EC World Reit (“EC”) may be one with DPU growth. I have the privilege of meeting Mr Goh Toh Sim, Executive Director & CEO of EC and Mr Li Jinbo, Head of Investment of EC (“Management”) for a 1-1 discussion […]

DBS – potential trading idea going to XD (26 Mar 18)

el15

Dear all, Based on a simple tracking of DBS’ share price performance from CD to XD, on average, DBS seems to move approximately 4-9% above its CD price, nearer to XD (translating to around S$27.86-29.13). See Table 1 below. DBS is going to XD $1.10 on 3 May. Table 1: DBS’ share price performance from CD to XD Source: Ernest’s compilations   What are the analysts saying? Based on Figure 1 below, average analyst target is around $31.15. At $27.21, this represents a potential capital upside of around 14.5%. Estimated div yield is around 4.1%. There are 17 buy; 6 […]

Ernest’s compilation of stocks sorted by estimated total potential return (29 Sep 17)

el15

Dear all S&P500 hit another record last Fri! Some private banking clients have enquired on any interesting stocks to take a closer look with a horizon of 1-3 years. Therefore, I have compiled a list of stocks based on Bloomberg’s data as of 29 Sep 2017. Table 1 shows only the top five stocks with the highest estimated total potential return. Table 1: List of top 5 stocks with the highest estimated total potential return Source: Bloomberg as of 29 Sep 2017   Noteworthy points 1. This compilation is based on Bloomberg’s data sorted with my set of criteria namely, a) […]

Ernest’s market opinion (19 May 17)

el15

Dear all Below is my personal opinion on the market. As previously mentioned to my clients, I aim to reduce my percentage invested in stocks (currently around 130% invested), especially the non-performing stocks, with no immediate near term catalysts. I am cautious on the market in the next 1-2 months because a) The large market run up year to date. STI has appreciated approximately 12% YTD and 22% for the past one year; b) June is likely to be a quiet month as most companies have reported results and some of the blue chips have already ex dividend. i.e. limited […]

Banyan Tree – collaborations with AccorHotels and Vanke may spark re-rating (17 Apr 17)

el15

Banyan Tree recently clinched two noteworthy strategic partnership with AccorHotels and Vanke on 8 Dec 2016 and 23 Jan 2017 respectively. Since 23 Jan 2017, Banyan has largely traded between $0.465 – 0.530. It closed at $0.510 on 17 Apr 2017. If a company can catch the eyes of China’s largest property player Vanke and Europe’s largest hotel group / the world’s fifth largest hotel group AccorHotels, there must be some merit to it. I have managed to fix an exclusive 1-1 meeting with Mr Eddy See, Group MD and Mr Clement Ong, Head of Strategic Planning & Investment (“Management”) […]